薬剤溶出ステント市場レポート：動向、予測、競合分析 (2031年まで)

世界の薬剤溶出ステント市場の将来は有望で、冠動脈疾患と末梢動脈疾患市場に機会があります。世界の薬剤溶出ステント市場は、2025年から2031年までのCAGRが6.3%で、2031年には推定137億米ドルに達すると予想されています。この市場の主な促進要因は、世界の高齢者人口の増加と心血管障害の発生率の上昇です。

• Lucintelの予測によると、コーティングの種類別では、ポリマー系コーティングはその効果と適応性が実証されているため、予測期間中も大きなセグメントであり続けます。
• 用途別市場では、世界の冠動脈疾患の罹患率の増加により、冠動脈疾患が引き続き大きなセグメントとなると思われます。
• 地域別では、北米は医療インフラが発達しており、先進医療技術が広く採用されていることから、予測期間中も最大地域であり続けると思われます。

薬剤溶出ステント市場の戦略的成長機会

DES市場は、主要用途におけるさまざまな戦略的機会によって成長を遂げています。これらの機会を特定し活用することで、市場での存在感を高め、患者の転帰を改善することができます。

• 新興市場への進出：アジア太平洋やラテンアメリカなどの新興市場は、心血管疾患罹患率の増加や医療投資の増加により、大きな成長機会となっています。これらの地域での市場プレゼンスを拡大することで、収益成長を促進し、先進ステント技術へのアクセスを増やすことができます。
• 次世代ステントの開発：薬物送達システムの改善、ストラットの薄型化、生分解性材料などを備えた次世代DESへの投資は、大きな成長の可能性をもたらします。こうした技術革新は現在の限界に対処し、ステント治療の有効性と安全性を高めるため、臨床医と患者の双方を惹きつけます。
• デジタルヘルス技術の統合：遠隔モニタリングやデータ解析などのデジタルヘルス技術をDES治療プロトコルに組み込むことで、患者の管理と転帰を改善することができます。これらの技術はステントの性能と患者のコンプライアンスをよりよく追跡することを可能にし、より効果的な治療につながります。
• 個別化医療の重視：個別化医療が重視されるようになったことで、個々の患者のニーズに合わせてカスタマイズされたDESソリューションを開発する機会が生まれています。遺伝子や臨床データを活用することで、メーカーは最適化された薬剤処方や設計のステントを作成し、治療効果を高めることができます。
• 画像診断の進歩：OCTや血管内超音波などの高度な画像技術をDESに組み込むことで、ステントの留置と展開の精度を向上させることができます。これらの進歩により、血管の状態をより的確に評価し、ステントのサイズをより正確に決めることが可能となり、患者の予後改善につながります。

DES市場における戦略的成長機会は、技術の進歩、市場の拡大、個別化アプローチによってもたらされます。利害関係者はこれらの機会を活用することで、市場での地位を高め、患者ケアの向上に貢献することができます。

薬剤溶出ステント市場の促進要因・課題

DES市場は、その成長軌道に影響を与えるさまざまな促進要因・課題によって形成されています。技術の進歩、経済的要因、規制上の問題は、市場のダイナミクスを決定し、利害関係者の戦略に影響を与える上で重要な役割を果たします。

薬剤溶出ステント市場を牽引する要因には、以下のようなものがあります：

• 技術進歩：薬物デリバリーシステムや生分解性材料を改良した次世代DESなど、ステント技術の革新が市場成長の原動力となっています。こうした進歩はステントの有効性と安全性を高め、患者の予後改善と採用率の向上につながります。
• 心血管疾患の有病率の増加：世界の心血管疾患の罹患率の上昇は、DES市場の重要な促進要因です。患者数の増加は効果的な治療オプションに対する高い需要を生み出し、DES技術の成長を促進します。
• 規制支援とイノベーション：規制プロセスの合理化と革新的医療機器への支援により、新しいDES技術の迅速な承認と市場参入が促進されています。このような規制環境は継続的な研究開発を促し、市場拡大を促進します。
• 医療支出の増加：医療支出の増加と先進医療技術への投資がDES市場の成長に寄与しています。心血管治療への予算増が最先端のステント技術の採用を可能にしています。
• 個別化医療への注目の高まり：個別化医療とオーダーメイド治療アプローチの重視がDESの技術革新を促進しています。個々の患者プロファイルに基づいたカスタマイズされたステント設計と薬剤処方により、治療成績と市場需要が向上します。

薬剤溶出ステント市場における課題は以下の通りです：

• 先進DESの高コスト：先進的DES技術の高コストは、特に新興市場においてアクセシビリティとアフォーダビリティを制限する可能性があります。この課題は、特にコストに敏感な地域での市場浸透率や採用率に影響します。
• 規制と償還のハードル：複雑な規制要件や償還の問題は、市場参入や拡大の課題となり得ます。これらのハードルを乗り越えるには多大なリソースと専門知識が必要となり、新しいDES技術の導入のスピードと容易さに影響を与えます。
• 競合と市場の飽和：DESメーカーや製品数の増加は、市場の飽和と競争の激化につながる可能性があります。競争が激化する中で製品を差別化し市場シェアを維持することは、企業にとって困難なことです。

技術の進歩や心血管疾患の増加といった市場促進要因がDES市場を前進させています。しかし、持続的な成長と市場開拓のためには、高コストや規制上のハードルといった課題に対処する必要があります。これらの要因のバランスを取ることがDES市場の将来を形成する上で極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界の薬剤溶出ステント市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の薬剤溶出ステント市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の薬剤溶出ステント市場：コーティングの種類別
  • ポリマー系コーティング
  • ポリマーフリーコーティング
• 世界の薬剤溶出ステント市場：用途別
  • 冠動脈疾患
  • 末梢動脈疾患

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の薬剤溶出ステント市場：地域別
• 北米の薬剤溶出ステント市場
• 欧州の薬剤溶出ステント市場
• アジア太平洋の薬剤溶出ステント市場
• その他地域の薬剤溶出ステント市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の薬剤溶出ステント市場の成長機会：コーティングの種類別
  • 世界の薬剤溶出ステント市場の成長機会：用途別
  • 世界の薬剤溶出ステント市場の成長機会：地域別
• 世界の薬剤溶出ステント市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の薬剤溶出ステント市場の生産能力拡大
  • 世界の薬剤溶出ステント市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

The future of the global drug-eluting stent market looks promising, with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $13.7 billion by 2031, with a CAGR of 6.3% from 2025 to 2031. The major drivers for this market are the increasing global elderly population and rising incidence of cardiovascular disorders.

• Lucintel forecasts that, within the coating type category market, polymer-based coatings will remain a larger segment over the forecast period due to their proven effectiveness and adaptability.
• Within the application category market, coronary artery disease will remain a larger segment due to the increasing global incidence of coronary artery disease.
• In terms of regions, North America will remain the largest region over the forecast period due to the presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Gain valuable insights for your business decisions with our 150+ page report.

Emerging Trends in the Drug-Eluting Stent Market

Emerging trends in the DES market reflect advancements in technology, changing patient demographics, and evolving healthcare needs. These trends are influencing product development, market dynamics, and treatment outcomes, providing insights into the future of cardiovascular interventions.

• Biodegradable Stents: Biodegradable stents are gaining traction due to their ability to dissolve over time, reducing the risk of long-term complications and eliminating the need for permanent implants. These stents offer the advantage of restoring natural vessel function after degradation, which is beneficial for patients with complex cardiovascular conditions.
• Advanced Drug Delivery Systems: New DES technologies feature improved drug delivery systems that enhance the precision and efficacy of medication release. This includes the development of stents with controlled drug elution rates and novel drug combinations, which help reduce restenosis and improve overall treatment outcomes.
• Personalized Medicine: The trend toward personalized medicine in DES involves tailoring stent designs and drug formulations to individual patient profiles. Advances in genomics and diagnostics are allowing for more customized treatment approaches, potentially leading to better outcomes and reduced adverse events.
• Integration of Imaging Technologies: The integration of advanced imaging technologies, such as optical coherence tomography (OCT), is enhancing the precision of stent placement and deployment. These technologies provide detailed insights into vessel characteristics, allowing for more accurate stent sizing and placement.
• Regulatory Changes: Regulatory bodies are adopting more flexible and accelerated approval processes for innovative DES technologies. This includes streamlined pathways for clinical trials and faster market access, which encourage the development and availability of new stent options.

These emerging trends are reshaping the DES market by driving innovation, improving patient outcomes, and increasing market accessibility. As technology advances and regulatory landscapes evolve, the DES market will continue to grow and adapt to meet the needs of patients and healthcare providers.

Recent Developments in the Drug-Eluting Stent Market

Recent developments in the DES market are characterized by technological innovations, regulatory updates, and evolving healthcare needs. These changes are transforming the landscape of cardiovascular treatments, improving patient outcomes, and driving market growth.

• Introduction of Next-Generation Stents: Next-generation DES featuring thinner struts and improved drug coatings are now available. These advancements contribute to reduced restenosis rates and enhanced biocompatibility, leading to better long-term outcomes and patient satisfaction.
• Biodegradable Stent Technologies: The development of biodegradable stents, which gradually dissolve over time, has become a significant trend. These stents reduce the risk of chronic complications associated with permanent implants and restore natural vessel function, offering a promising alternative to traditional DES.
• Enhanced Drug Delivery Systems: Advances in drug delivery technologies, such as controlled-release mechanisms and novel drug formulations, are improving the efficacy of DES. These innovations ensure more precise and effective medication delivery, reducing the likelihood of restenosis and stent thrombosis.
• Increased Focus on Personalized Medicine: Personalized medicine is gaining traction, with DES being tailored to specific patient needs based on genetic and clinical profiles. This approach aims to optimize treatment outcomes by addressing individual variations in disease and response to therapy.
• Regulatory Changes and Market Access: Regulatory bodies are adopting more streamlined approval processes for innovative DES technologies. These changes facilitate quicker market entry for new stent designs and improve access to advanced treatment options for patients.

These recent developments are driving significant changes in the DES market, leading to improved patient outcomes and expanding market opportunities. As technology and regulations continue to evolve, the DES market is expected to grow and adapt to new challenges and opportunities.

Strategic Growth Opportunities for the Drug-Eluting Stent Market

The DES market is experiencing growth driven by various strategic opportunities in key applications. Identifying and leveraging these opportunities can lead to enhanced market presence and improved patient outcomes.

• Expansion into Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, present significant growth opportunities due to increasing cardiovascular disease prevalence and rising healthcare investments. Expanding market presence in these regions can drive revenue growth and increase access to advanced stent technologies.
• Development of Next-Generation Stents: Investment in next-generation DES with improved drug delivery systems, thinner struts, and biodegradable materials offers substantial growth potential. These innovations address current limitations and enhance the efficacy and safety of stent treatments, attracting both clinicians and patients.
• Integration of Digital Health Technologies: Incorporating digital health technologies, such as remote monitoring and data analytics, into DES treatment protocols can improve patient management and outcomes. These technologies enable better tracking of stent performance and patient compliance, leading to more effective treatments.
• Focus on Personalized Medicine: The growing emphasis on personalized medicine presents opportunities for developing customized DES solutions tailored to individual patient needs. By leveraging genetic and clinical data, manufacturers can create stents with optimized drug formulations and designs, enhancing treatment efficacy.
• Advancements in Imaging and Diagnostics: Integrating advanced imaging technologies, such as OCT and intravascular ultrasound, with DES can improve the precision of stent placement and deployment. These advancements allow for better assessment of vessel conditions and more accurate stent sizing, leading to improved patient outcomes.

Strategic growth opportunities in the DES market are driven by technological advancements, market expansion, and personalized approaches. By capitalizing on these opportunities, stakeholders can enhance their market position and contribute to improved patient care.

Drug-Eluting Stent Market Driver and Challenges

The DES market is shaped by a range of drivers and challenges that impact its growth trajectory. Technological advancements, economic factors, and regulatory issues play a crucial role in determining market dynamics and influencing stakeholder strategies.

The factors responsible for driving the drug-eluting stent market include:

• Technological Advancements: Innovations in stent technology, such as next-generation DES with improved drug delivery systems and biodegradable materials, are driving market growth. These advancements enhance the efficacy and safety of stents, leading to better patient outcomes and increased adoption.
• Growing Cardiovascular Disease Prevalence: The rising incidence of cardiovascular diseases globally is a significant driver for the DES market. Increasing patient numbers create a higher demand for effective treatment options, driving the growth of DES technologies.
• Regulatory Support and Innovation: Streamlined regulatory processes and support for innovative medical devices are facilitating faster approval and market entry for new DES technologies. This regulatory environment encourages ongoing research and development, driving market expansion.
• Rising Healthcare Expenditure: Increased healthcare spending and investment in advanced medical technologies are contributing to the growth of the DES market. Higher budgets for cardiovascular treatments enable the adoption of cutting-edge stent technologies.
• Growing Focus on Personalized Medicine: The emphasis on personalized medicine and tailored treatment approaches is driving innovation in DES. Customized stent designs and drug formulations based on individual patient profiles improve treatment outcomes and market demand.

Challenges in the drug-eluting stent market are:

• High Cost of Advanced DES: The high cost of advanced DES technologies can limit accessibility and affordability, particularly in emerging markets. This challenge affects market penetration and adoption rates, especially in cost-sensitive regions.
• Regulatory and Reimbursement Hurdles: Complex regulatory requirements and reimbursement issues can pose challenges for market entry and expansion. Navigating these hurdles requires significant resources and expertise, impacting the speed and ease of introducing new DES technologies.
• Competition and Market Saturation: The growing number of DES manufacturers and products can lead to market saturation and intensified competition. Differentiating products and maintaining market share amidst increasing competition can be challenging for companies.

Drivers such as technological advancements and growing cardiovascular disease prevalence are propelling the DES market forward. However, challenges like high costs and regulatory hurdles need to be addressed to ensure sustained growth and market development. Balancing these factors will be crucial for shaping the future of the DES market.

List of Drug-Eluting Stent Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, drug-eluting stent companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

Drug-Eluting Stent by Segment

The study includes a forecast for the global drug-eluting stent market by coating type, application, and region.

Drug-Eluting Stent Market by Coating Type [Analysis by Value from 2019 to 2031]:

• Polymer-Based Coating
• Polymer-Free Coating

Drug-Eluting Stent Market by Application [Analysis by Value from 2019 to 2031]:

• Coronary Artery Disease
• Peripheral Artery Disease

Drug-Eluting Stent Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Drug-Eluting Stent Market

The drug-eluting stent (DES) market has experienced significant advancements in recent years, driven by technological innovations, regulatory changes, and evolving patient needs. These developments are reshaping market dynamics across various countries. This summary provides an overview of recent trends and advancements in the DES market in the United States, China, Germany, India, and Japan.

• United States: In the U.S., recent advancements include the introduction of next-generation DES with enhanced biocompatibility and thinner struts, which reduce restenosis rates and improve patient outcomes. The FDA's streamlined approval process for innovative stent technologies has accelerated market entry. Additionally, there is a growing emphasis on personalized medicine, with stent designs tailored to specific patient demographics and conditions.
• China: China's DES market has seen rapid growth due to increasing cardiovascular disease prevalence and advancements in medical technology. Local manufacturers are investing heavily in research and development to produce cost-effective DES, leading to a rise in domestic production. Regulatory reforms have also facilitated faster approval of new DES technologies, boosting market growth.
• Germany: Germany remains a leader in the DES market in Europe, driven by its strong healthcare infrastructure and emphasis on advanced medical technologies. Recent developments include the adoption of biodegradable stents and innovations in drug delivery systems, which enhance the long-term safety and efficacy of DES. The German market also benefits from a robust reimbursement framework that supports the adoption of cutting-edge stent technologies.
• India: In India, the DES market is expanding due to increasing cardiovascular disease incidence and rising healthcare expenditure. Local and international companies are introducing affordable DES solutions to cater to the growing patient base. The Indian government's initiatives to improve healthcare access and infrastructure are also contributing to the market's growth.
• Japan: Japan's DES market is characterized by high adoption rates of advanced stent technologies and a focus on improving patient outcomes through innovation. Recent developments include the introduction of ultra-thin strut stents and advanced drug formulations. Japan's stringent regulatory standards ensure that only high-quality DES are approved, maintaining a high standard for patient care.

Features of the Global Drug-Eluting Stent Market

Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).

Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the drug-eluting stent market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug-Eluting Stent Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Drug-Eluting Stent Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Drug-Eluting Stent Market by Coating Type
  • 3.3.1: Polymer-Based Coating
  • 3.3.2: Polymer-Free Coating
• 3.4: Global Drug-Eluting Stent Market by Application
  • 3.4.1: Coronary Artery Disease
  • 3.4.2: Peripheral Artery Disease

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Drug-Eluting Stent Market by Region
• 4.2: North American Drug-Eluting Stent Market
  • 4.2.1: North American Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.2.2: North American Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.3: European Drug-Eluting Stent Market
  • 4.3.1: European Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.3.2: European Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.4: APAC Drug-Eluting Stent Market
  • 4.4.1: APAC Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.4.2: APAC Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.5: ROW Drug-Eluting Stent Market
  • 4.5.1: ROW Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.5.2: ROW Market by Application: Coronary Artery Disease and Peripheral Artery Disease

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
  • 6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
  • 6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
• 6.2: Emerging Trends in the Global Drug-Eluting Stent Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific
• 7.2: Medtronic
• 7.3: Abbott Laboratories
• 7.4: Biosensors
• 7.5: Biotronik
• 7.6: Lepu Medical Technology
• 7.7: Terumo Medical
• 7.8: Cook Medical
• 7.9: Shandong JW Medical Systems
• 7.10: B.Braun